To address this goal, we initially compared the levels of GDF15 in AH and serum samples from the same cohort of POAG patients (n = 40 and 41, respectively) with age- and gender-matched controls (non-glaucomatous, cataract patients, n = 32). This evidence concerns the gene GDF15 and open-angle glaucoma.